	US 11,833,242 B2
	Skin care formulations
Patricia McGill Boland, Houston, TX (US); Deborah Eileen Gregg Bouche, Houston, TX (US); John Anthony Garruto, Encinitas, CA (US); and Bethany Ann McCarver, Oceanside, CA (US)
Assigned to COLORESCIENCE, INC., Carlsbad, CA (US)
Filed by Colorescience, Inc., Carlsbad, CA (US)
Filed on Aug. 5, 2022, as Appl. No. 17/817,759.
Application 17/817,759 is a continuation of application No. 17/302,627, filed on May 7, 2021, granted, now 11,433,020.
Application 17/302,627 is a continuation of application No. 16/388,278, filed on Apr. 18, 2019.
Application 16/388,278 is a continuation of application No. 15/965,205, filed on Apr. 27, 2018, granted, now 10,285,932, issued on May 14, 2019.
Application 15/965,205 is a continuation in part of application No. 14/735,778, filed on Jun. 10, 2015, granted, now 9,956,163, issued on May 1, 2018.
Claims priority of provisional application 62/538,390, filed on Jul. 28, 2017.
Claims priority of provisional application 62/011,472, filed on Jun. 12, 2014.
Prior Publication US 2022/0370338 A1, Nov. 24, 2022
Int. Cl. A61K 8/9789 (2017.01); A61K 8/9722 (2017.01); A61K 8/9711 (2017.01); A61K 8/9717 (2017.01); A61K 8/73 (2006.01); A61K 8/41 (2006.01); A61Q 19/02 (2006.01); A61K 8/9728 (2017.01); A61K 8/60 (2006.01); A61Q 19/08 (2006.01); A61Q 19/00 (2006.01); A61K 8/19 (2006.01); A61K 8/27 (2006.01); A61K 8/29 (2006.01); A61K 8/34 (2006.01); A61K 8/368 (2006.01); A61K 8/49 (2006.01); A61K 8/55 (2006.01); A61K 8/891 (2006.01); A61Q 17/04 (2006.01)

CPC A61K 8/9789 (2017.08) [A61K 8/19 (2013.01); A61K 8/27 (2013.01); A61K 8/29 (2013.01); A61K 8/34 (2013.01); A61K 8/368 (2013.01); A61K 8/416 (2013.01); A61K 8/498 (2013.01); A61K 8/4926 (2013.01); A61K 8/55 (2013.01); A61K 8/602 (2013.01); A61K 8/733 (2013.01); A61K 8/891 (2013.01); A61K 8/9711 (2017.08); A61K 8/9717 (2017.08); A61K 8/9722 (2017.08); A61K 8/9728 (2017.08); A61Q 17/04 (2013.01); A61Q 19/00 (2013.01); A61Q 19/007 (2013.01); A61Q 19/02 (2013.01); A61Q 19/08 (2013.01); A61K 2800/30 (2013.01); A61K 2800/43 (2013.01); A61K 2800/72 (2013.01)]

14 Claims

1. A cosmetic formulation comprising:

bisabolol, wherein the bisabolol is present in an amount between 0.05 to 5%;

disodium lauriminodipropionate tocopheryl phosphates, wherein the disodium lauriminodipropionate tocopheryl phosphates are present in an amount between 0.1 and 1%;

tremella fuciformis sporocarp (Silver Ear mushroom) extract, wherein the Tremella fuciformis sporocarp (silver ear mushroom) extract is present in an amount between 0.05 and 0.4%;

niacinamide, wherein the niacinamide is present in an amount between 0.05 and 5%;

salicylate, wherein the salicylate is present in an amount between 1 and 10%;

a preservative,

at least one iron oxide selected from the group consisting of CI 77491, CI 77492, and CI 77499, wherein the at least one iron oxide is present in an amount between 0.01 and 5%; and

at least one of zinc oxide and titanium dioxide, wherein the at least one of zinc oxide and titanium dioxide is present in an amount between 5 and 15%;

wherein the formulation simultaneously provides color coverage, skin hydration and sun protection and wherein the percentages for each ingredient are with respect to the total formulation.